.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer last year f...
.On the heels of a period 3 gain that failed to impress investors, Ironwood Pharmaceuticals is back ...
.Do not quit Monte Rosa Therapies currently. The Boston-based biotech is actually having a ball afte...
.Invite to today's Chutes & Ladders, our roundup of considerable management hirings, firings and ...
.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has come back to the source of its antipsychotic goliath Vraylar trying to find an additiona...
.GenSight Biologics is weeks far from running out of loan. Again. The biotech simply has enough cash...
.Monopar Therapies is recuperating a medication coming from the dump of AstraZeneca's unusual ailmen...
.Along with new records out on Arcus Biosciences' experimental HIF-2a prevention, one team of expert...
.After forming a gene treatment collaboration with Dyno Rehabs in 2020, Roche is back for additional...